Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Adtalem (ATGE) To Report Earnings Tomorrow: Here Is What To Expect

Published 2024-08-05, 03:10 a/m
Adtalem (ATGE) To Report Earnings Tomorrow: Here Is What To Expect
ATGE
-
TAL
-

Stock Story -

Vocational education company Adtalem Global Education (NYSE:ATGE) will be announcing earnings results tomorrow after market hours. Here's what to look for.

Adtalem beat analysts' revenue expectations by 5.4% last quarter, reporting revenues of $412.7 million, up 11.8% year on year. It was a strong quarter for the company, with an impressive beat of analysts' earnings estimates and full-year revenue guidance exceeding analysts' expectations.

Is Adtalem a buy or sell going into earnings? Find out by reading the original article on StockStory, it's free.

This quarter, analysts are expecting Adtalem's revenue to grow 9.3% year on year to $398.6 million, improving from the 1.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.28 per share.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Adtalem has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 3.3% on average.

Looking at Adtalem's peers in the education services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Strategic Education delivered year-on-year revenue growth of 8.5%, beating analysts' expectations by 1.3%, and Laureate Education reported revenues up 8%, topping estimates by 3.2%. Strategic Education traded down 19.8% following the results while Laureate Education was also down 7.6%.

Read the full analysis of Strategic Education's and Laureate Education's results on StockStory.

There has been positive sentiment among investors in the education services segment, with share prices up 3.3% on average over the last month. Adtalem is up 9.3% during the same time and is heading into earnings with an average analyst price target of $78.7 (compared to the current share price of $74.52).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.